Migdal Insurance & Financial Holdings Ltd. Hepion Pharmaceuticals, Inc. Transaction History

Migdal Insurance & Financial Holdings Ltd.

  • $5.99 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 02, 2022
SELL
$0.93 - $1.29 $1,513 - $2,098
-1,627 Closed
0 $0
Q4 2021

Feb 02, 2022
SELL
$1.14 - $1.58 $1,117 - $1,548
-980 Reduced 37.59%
1,627 $2,000
Q3 2021

Nov 16, 2021
BUY
$1.39 - $2.1 $3,623 - $5,474
2,607 New
2,607 $4,000

About Hepion Pharmaceuticals, Inc.

HEPA Quotes by TradingView
  • Ticker HEPA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,229,600
  • Market Cap $57.2M
  • Description
  • Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver...
More about HEPA
Track This Portfolio

Track Migdal Insurance & Financial Holdings Ltd. Portfolio

Follow Migdal Insurance & Financial Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Migdal Insurance & Financial Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Migdal Insurance & Financial Holdings Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email